XBiotech (XBIT)

• Market cap: $70.7M
• 1 day: -3.73%
• 5 days: -4.13%
• 1 month: 1.31%
• 3 months: -23.18%
• 6 months: -18.88%
• Year to date: -44.36%
• 1 year: -67.55%
• 5 years: -87.66%
• 10 years: -72.61%
• Sector: Healthcare
• Industry: Biotechnology

About: XBiotech Inc is a United States-based clinical-stage biopharmaceutical company. The company is engaged in discovering and developing True Human (antibody technology) monoclonal antibodies for treating a variety of diseases. The company focuses on developing Anti-inflammatory therapeutic antibodies as a treatment for cancer. Geographically, all of its operations are in the United States.

Employees: 88